Hematology NewsIn young MCL patients, optimal treatment may varyMay 4, 2018Mantle Cell LymphomaIndolent Lymphoma
Hematology NewsPDPK1 could be novel target in MCLApril 13, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsIbrutinib plus venetoclax is active in mantle cell lymphomaMarch 28, 2018Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology NewsTime to rethink MCL treatment, trial designMarch 14, 2018Mantle Cell LymphomaAggressive Lymphomas
Hematology NewsOutpatient CAR T infusions feasible using liso-celMarch 12, 2018Aggressive LymphomasLymphoma & Plasma Cell DisordersCellular TherapyImmunotherapyMantle Cell LymphomaFollicular Lymphoma
Hematology NewsIbrutinib linked to invasive fungal infectionsMarch 7, 2018CLLPatient & Survivor CareLeukemia, Myelodysplasia, TransplantationIndolent LymphomaMantle Cell Lymphoma
Hematology NewsAcalabrutinib shows less off-target activity in mantle cell lymphomaMarch 2, 2018Mantle Cell LymphomaAggressive Lymphomas
Hematology NewsNF-kappaB pathway could help solve resistance problem in mantle cell lymphomaFebruary 16, 2018Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsTriple therapy ups response in refractory mantle cell lymphomaFebruary 4, 2018Mantle Cell LymphomaIndolent LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsVcR-CVAD yields high responses, ‘excellent’ survival in MCLJanuary 11, 2018Mantle Cell LymphomaAggressive Lymphomas
Hematology NewsBTK inhibitor zanubrutinib active in non-Hodgkin lymphomasJanuary 2, 2018Mantle Cell LymphomaIndolent LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Hematology NewsVIDEO - New lymphoma drug approvals: Clinical use, future directionsDecember 14, 2017Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell DisordersImmuno-oncologyFollicular Lymphoma
Hematology NewsVIDEO: Ibrutinib PFS is nearly 3 years in MCL patients who had one prior therapyDecember 13, 2017Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive Lymphomas
Hematology NewsAvapritinib yields high response rate in patients with systemic mastocytosisDecember 10, 2017Myelodysplastic SyndromeMantle Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsRituximab key to survival after transplant for mantle cell lymphomaNovember 16, 2017Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAggressive Lymphomas
